Biotechnology Stocks
| # | Ultimi 7 Giorni | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 4849 |  XCUR Exicure, Inc. - Common Stock | 1.14 USD | -0.87% | -11.63% | -33.72% | -81.00% | 7.46 M USD | ||
| 4852 |  ALZN Alzamend Neuro, Inc. - Common Stock | 1.46 USD | -6.41% | -5.81% | +8.15% | -40.41% | 7.00 M USD | ||
| 4856 |  CURX Curanex Pharmaceuticals Inc - Common Stock | 4.58 USD | -2.76% | +1981.82% | +2190.00% | +20.53% | 7.18 M USD | ||
| 4860 |  ENSC Ensysce Biosciences, Inc. - Common Stock | 0.36 USD | -2.70% | -7.69% | +38.46% | -5.26% | 7.00 M USD | ||
| 4862 |  BOLT Bolt Biotherapeutics, Inc. - Common Stock | 3.78 USD | +3.00% | +15.24% | -5.97% | -26.46% | 7.28 M USD | ||
| 4866 |  LIMN Liminatus Pharma, Inc. - Class A Common Stock | 4.88 USD | -5.24% | +3385.71% | +4336.36% | +48.78% | 6.55 M USD | ||
| 4873 |  IMRN Immuron Limited - American Depositary Shares | 1.14 USD | 0.00% | +2.70% | +1.79% | -36.67% | 6.67 M USD | ||
| 4880 |  XTLB XTL Biopharmaceuticals Ltd - American Depositary Shares | 2.76 USD | 0.00% | +4.15% | -3.50% | +206.67% | 6.53 M USD | ||
| 4886 |  ENVB Enveric Biosciences, Inc. - Common Stock | 1.40 USD | -2.10% | -3.45% | +6.06% | -43.09% | 6.27 M USD | ||
| 4887 |  NCNA NuCana plc - American Depositary Shares | 1.49 USD | -1.97% | -2.61% | +9.56% | -30.70% | 6.20 M USD | ||
| 4894 |  ADXN Addex Therapeutics Ltd - American Depositary Shares | 4.50 USD | -8.91% | -23.34% | -22.41% | -43.04% | 5.54 M USD | ||
| 4900 |  CDIO Cardio Diagnostics Holdings Inc. - Common stock | 1.93 USD | -4.93% | -5.39% | +25.32% | -26.34% | 5.71 M USD | ||
| 4910 |  PCSA Processa Pharmaceuticals, Inc. - Common Stock | 2.07 USD | -0.48% | -8.81% | -23.05% | -6.76% | 5.78 M USD | ||
| 4914 |  BGMS Bio Green Med Solution, Inc. - Common Stock | 0.88 USD | +1.15% | -4.35% | -2.22% | -85.33% | 5.83 M USD | ||
| 4915 |  CVKD Cadrenal Therapeutics, Inc. - Common Stock | 1.64 USD | +1.86% | -7.34% | -23.36% | -70.29% | 5.85 M USD | ||
| 4918 |  DRMA Dermata Therapeutics, Inc. - Common Stock | 1.43 USD | +0.70% | +2.88% | +11.72% | 0.00% | 5.75 M USD | ||
| 4921 |  PMCB PharmaCyte Biotech, Inc. - Common Stock | 0.53 USD | 0.00% | -3.64% | -11.67% | -44.21% | 5.69 M USD | ||
| 4924 |  BRTX BioRestorative Therapies, Inc. - Common Stock | 0.23 USD | +4.55% | 0.00% | -20.69% | -84.97% | 5.86 M USD | ||
| 4929 |  PULM Pulmatrix, Inc. - Common Stock | 1.43 USD | -4.67% | -5.30% | -12.80% | -70.70% | 5.22 M USD | ||
| 4932 |  BCAB BioAtla, Inc. - Common Stock | 3.41 USD | +5.25% | +10.00% | +2.10% | +847.22% | 5.68 M USD |
Notizie Biotechnology Stocks
Deutsche Bank declassa argenx a Hold per valutazione
Perché il titolo di Monte Rosa Therapeutics scende oggi?
Il titolo di Biomea Fusion balza dopo il completamento dell’arruolamento nel trial sul diabete
Il titolo di Monte Rosa cala con l’avvio dello studio di fase 2 sul cancro alla prostata
H.C. Wainwright conferma il rating su Biomea Fusion dopo l’arruolamento nel trial
Il titolo azionario di Crinetics Pharmaceuticals raggiunge il massimo storico a 84,8 USD
La FDA estende la revisione di deramiocel di Capricor al 22 novembre
Gainers Biotechnology Stocks
 SKYE Skye Bioscience, Inc. - Common Stock | 2.11 | +653.57% |
 RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0038 | +280.00% |
 ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
 NTRBW Nutriband Inc. - Warrant | 0.7500 | +50.00% |
 OABIW OmniAb, Inc. - Warrant | 0.2339 | +37.59% |
 LSTA Lisata Therapeutics, Inc. - Common Stock | 1.98 | +27.74% |
 BMEA Biomea Fusion, Inc. - Common Stock | 1.68 | +22.63% |
 CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.1098 | +19.09% |
Losers Biotechnology Stocks
 HUMAW Humacyte, Inc. - Warrant | 0.0050 | -44.44% |
 CINGW Cingulate Inc. - Warrants | 0.0060 | -34.07% |
 RGNX REGENXBIO Inc. - Common Stock | 8.14 | -24.07% |
 ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.25 | -15.59% |
 APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
 BCTX BriaCell Therapeutics Corp. - Common Shares | 3.61 | -11.30% |
 YDESW YD Bio Limited - Warrants | 0.3642 | -11.17% |
 SNTI Senti Biosciences, Inc. - Common Stock | 0.35 | -10.26% |